Israeli Covid Drug Also Aids Cancer Immunotherapy Patients
Diana Bletter via Israel21c – Israeli biotechnology company Bonus BioGroup announced that its Covid drug, MesenCure, can also reduce life-threatening inflammatory overreaction in cancer patients treated…
Drug Saves 47 of 50 Severe Covid Patients in Trial
Abigail Klein Leichman via Israel21c – Israel’s Bonus BioGroup reports a survival rate of 94 percent (47 of 50) of the severe Covid-19 patients treated with its…